IP Library › Assignment 058007/0978
Patent Assignment
Reel/Frame 058007/0978

Assignment of Assignor's Interest

Recorded: 2021-11-03 Pages: 4
Assignor
PROMETHEUS LABORATORIES INC.
Executed: 2021-09-28
Assignee
EXAGEN INC.
1261 LIBERTY WAY, VISTA, CALIFORNIA, 92081
Covered Properties (4)
Methods of Quantifying Methotrexate Metabolites
Patent: 7,563,590 →
Application: 10/232,760 →
Publication: US 2004/0043441
Methods for Direct Detection of Individual Methotrexate Metabolites
Patent: 6,921,667 →
Application: 10/384,066 →
Publication: US 2004/0175834
Methods for Optimizing Clinical Responsiveness to Methotrexate Therapy Using Metabolite Profiling and Pharmacogenetics
Patent: 7,582,282 →
Application: 10/927,904 →
Publication: US 2005/0112627
Methods for Predicting Methotrexate Polyglutamate Levels Using Pharmacogenetics
Patent: 7,695,908 →
Application: 11/152,128 →
Publication: US 2006/0057609
Related Assignments (14)
Other recorded transfers of the patents in this record — the chain of ownership.
Short-Form Patent Security Agreement Oct 15, 2013
From: EXAGEN DIAGNOSTICS, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 031414/0660 →
Release of Security Interest Dec 29, 2015
From: BANK OF AMERICA, N.A.
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 037378/0464 →
Release of Security Interest Sep 1, 2017
From: CYPRESS BIOSCIENCE INC.
To: EXAGEN DIAGNOSTICS, INC.
Reel/Frame 043747/0382 →
Release of Security Interest Sep 7, 2017
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: EXAGEN DIAGNOSTICS, INC.
Reel/Frame 043784/0828 →
Security Interest Sep 11, 2017
From: EXAGEN DIAGNOSTICS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 043548/0228 →
Merger Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
Corrective Assignment to Correct the English Translation to Show the Full and Correct New Name in Section 51. Previously Recorded at Reel: 049391 Frame: 0756. Assignor(S) Hereby Confirms the Merger. Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
Assignment of Assignor's Interest Aug 26, 2019
From: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
To: PRECISION IBD, INC.
Reel/Frame 050166/0001 →
Change of Name Oct 17, 2019
From: PRECISION IBD, INC.
To: PROMETHEUS BIOSCIENCES, INC.
Reel/Frame 050886/0942 →
Corrective Assignment to Correct the Patent Number 16062921 Previously Recorded on Reel 049391 Frame 0756. Assignor(S) Hereby Confirms the Patent Number Should Have Been 16062912. Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
Corrective Assignment to Correct the Patent Number 16062921 Previously Recorded on Reel 049391 Frame 0756. Assignor(S) Hereby Confirms the Patent Number Should Have Been 16062912. Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
Assignment of Assignor's Interest Oct 7, 2021
From: PROMETHEUS BIOSCIENCES, INC.
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 057730/0993 →
Release of Security Interest Apr 25, 2025
From: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
To: EXAGEN INC.
Reel/Frame 070951/0040 →
Security Interest Apr 25, 2025
From: EXAGEN INC.
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 070952/0802 →